Company Overview of Eurogentec S.A.
Eurogentec S.A. manufactures and distributes reagents, kits, and specialty products to life science, diagnostic, and pharmaceutical markets. Its life science research business unit provides R&D laboratories with reagents and related services for genomics and proteomics. The company offers oligonucleotides; qPCR and qRT-PCR kits, qPCR consumables, and dispensing services; peptides; antibodies that include custom polyclonals and monoclonals, and catalogue antibodies; and other biochemicals, such as PCR and RT-PCR, DNA extraction and purifications kits, electrophoresis, transformation, protein production and analysis, and synthesis reagent products. It also provides good manufacturing practices...
LIEGE Science Park
Rue du Bois Saint Jean 5
Founded in 1985
Key Executives for Eurogentec S.A.
Chief Executive Officer and Director
Chairman of The Board and Chief Operation Officer
Biologics Business Unit Director
Compensation as of Fiscal Year 2017.
Eurogentec S.A. Key Developments
Eurogentec S.A. Presents at BIO Europe 2016 Conference, Nov-07-2016
Sep 2 16
Eurogentec S.A. Presents at BIO Europe 2016 Conference, Nov-07-2016 . Venue: KoelnMesse - Congress Center North, Cologne, Germany.
Scancell Holdings Announces Manufacture Agreement with Eurogentec S.A
Jul 21 16
Scancell Holdings PLC announced an agreement with Eurogentec S.A, an FDA inspected CMO specialised in the GMP production of plasmid DNA and recombinant proteins, for the manufacture of new supplies of Scancell's SCIB1 ImmunoBody® vaccine for use in the US clinical study of SCIB1 in combination with a checkpoint inhibitor, expected to commence in 2017. Upon completion and once fully evaluated, which is expected to take approximately 9-12 months, this clinical trial material will also be available to recommence dosing of patients in the company's long-term extension of the Phase 1/2 SCIB1 clinical study in malignant melanoma (subject to regulatory approval). Eurogentec's biologics division produces clinical trial and commercial biopharmaceutical material compliant with current Good Manufacturing Practice (cGMP) for all major markets according to US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) requirements. The company is FDA inspected (2011, 2013, 2014) and currently manufactures a biopharmaceutical marketed in the US. In the field of plasmid DNA, Eurogentec is a recognised leading CMO having recently manufactured 150g of plasmid DNA material for a major pharmaceutical company with plans to scale the process to commercial requirements.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries